{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:11:35Z","timestamp":1793470295750,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.idc.2023.12.004","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T01:24:16Z","timestamp":1706232256000},"page":"87-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Management of Ventilator-Associated Pneumonia"],"prefix":"10.1016","volume":"38","author":[{"given":"Mark L.","family":"Metersky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre C.","family":"Kalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2023.12.004_bib1","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1001\/jama.2016.16226","article-title":"Trend in ventilator-associated pneumonia rates between 2005 and 2013","volume":"316","author":"Metersky","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2023.12.004_bib2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S1473-3099(13)70081-1","article-title":"Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies","volume":"13","author":"Melsen","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2023.12.004_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/664049","article-title":"Economic impact of ventilator-associated pneumonia in a large matched cohort","volume":"33","author":"Kollef","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl 1","key":"10.1016\/j.idc.2023.12.004_bib4","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/653060","article-title":"Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia","volume":"51","author":"Muscedere","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2023.12.004_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idc.2023.12.004_bib6","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American Thoracic society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.idc.2023.12.004_bib7","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1017\/S0899823X00193894","article-title":"Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update","volume":"35","author":"Klompas","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.idc.2023.12.004_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.idc.2023.12.004_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/sur.2012.030","article-title":"Bacteremia and ventilator-associated pneumonia: a marker for contemporaneous extra-pulmonic infection","volume":"15","author":"Kunac","year":"2014","journal-title":"Surg Infect (Larchmt)"},{"issue":"4","key":"10.1016\/j.idc.2023.12.004_bib10","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1378\/chest.116.4.1075","article-title":"Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia","volume":"116","author":"Luna","year":"1999","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.idc.2023.12.004_bib11","article-title":"Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia","author":"Berton","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.idc.2023.12.004_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.CCM.0000253404.69418.AA","article-title":"Ventilator-associated pneumonia: breaking the vicious circle of antibiotic overuse","volume":"35","author":"Leone","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2023.12.004_bib13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1378\/chest.111.3.676","article-title":"Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia","volume":"111","author":"Luna","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.idc.2023.12.004_bib14","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1086\/651075","article-title":"Validation of the American Thoracic Society-Infectious Diseases Society of America guidelines for hospital-acquired pneumonia in the intensive care unit","volume":"50","author":"Ferrer","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2023.12.004_bib15","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.4187\/respcare.02173","article-title":"Comparison of the bacterial etiology of early-onset and late-onset ventilator-associated pneumonia in subjects enrolled in 2 large clinical studies","volume":"58","author":"Restrepo","year":"2013","journal-title":"Respir Care"},{"key":"10.1016\/j.idc.2023.12.004_bib16","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00134-012-2808-5","article-title":"Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors","volume":"39","author":"Martin-Loeches","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.idc.2023.12.004_bib17","doi-asserted-by":"crossref","first-page":"e89984","DOI":"10.1371\/journal.pone.0089984","article-title":"The impact of antimicrobial resistance and aging in VAP outcomes: experience from a large tertiary care center","volume":"9","author":"Arvanitis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.idc.2023.12.004_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jiph.2015.09.002","article-title":"The impact of onset time on the isolated pathogens and outcomes in ventilator associated pneumonia","volume":"9","author":"Khan","year":"2016","journal-title":"J\u00a0Infect Public Health"},{"key":"10.1016\/j.idc.2023.12.004_bib19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1164\/ajrccm.159.1.9803097","article-title":"Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia","volume":"159","author":"Ewig","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idc.2023.12.004_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/ANA.0b013e3181bdf52f","article-title":"Retrospective analysis of the risk factors and pathogens associated with early-onset ventilator-associated pneumonia in surgical-ICU head-trauma patients","volume":"22","author":"Lepelletier","year":"2010","journal-title":"J\u00a0Neurosurg Anesthesiol"},{"key":"10.1016\/j.idc.2023.12.004_bib21","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1378\/chest.123.6.2034","article-title":"Hospital-acquired pneumonia: risk factors for antimicrobial-resistant causative pathogens in critically ill patients","volume":"123","author":"Leroy","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.idc.2023.12.004_bib22","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1164\/rccm.201708-1717LE","article-title":"Evaluation of the 2016 Infectious Diseases Society of America\/American Thoracic Society guideline criteria for risk of multidrug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia in the ICU","volume":"197","author":"Ekren","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idc.2023.12.004_bib23","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15\u00a0days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.idc.2023.12.004_bib24","article-title":"Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults","author":"Pugh","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.idc.2023.12.004_bib25","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1378\/chest.13-0076","article-title":"Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis","volume":"144","author":"Dimopoulos","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.idc.2023.12.004_bib26","unstructured":"Phase III study with Amikacin Inhale in intubated and mechanically ventilated patients with gram-negative pneumonia does not meet primary endpoint of superiority. 2017. https:\/\/www.prnewswire.com\/news-releases\/phase-iii-study-with-amikacin-inhale-in-intubated-and-mechanically-ventilated-patients-with-gram-negative-pneumonia-does-not-meet-primary-endpoint-of-superiority-300561095.html. Accessed April 10, 2018."},{"key":"10.1016\/j.idc.2023.12.004_bib27","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.chest.2016.11.026","article-title":"A\u00a0randomized trial of the Amikacin Fosfomycin inhalation system for the adjunctive therapy of gram-negative ventilator-associated pneumonia: IASIS trial","volume":"151","author":"Kollef","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.idc.2023.12.004_bib28","series-title":"Pharmacokinetic\/pharmacodynamic measures for guiding antibiotic treatment for hospital-acquired pneumonia","author":"Lux","year":"2014"},{"key":"10.1016\/j.idc.2023.12.004_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/2110-5820-2-37","article-title":"Continuous beta-lactam infusion in critically ill patients: the clinical evidence","volume":"2","author":"Abdul-Aziz","year":"2012","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.idc.2023.12.004_bib30","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00134-015-4188-0","article-title":"Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis","volume":"42","author":"Abdul-Aziz","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.idc.2023.12.004_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1473-3099(17)30615-1","article-title":"Prolonged versus short-term intravenous infusion of antipseudomonal beta-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials","volume":"18","author":"Vardakas","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2023.12.004_bib32","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1183\/09031936.00053209","article-title":"Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study","volume":"34","author":"Stolz","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.idc.2023.12.004_bib33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"Use of procalcitonin to reduce patients\u2019 exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial","volume":"375","author":"Bouadma","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.idc.2023.12.004_bib34","first-page":"A212","article-title":"Procalcitonin (PCT) guided antibiotic treatment in ventilator associated pneumonia (VAP). Multi-centre, clinical prospective, randomized-controlled study","volume":"175","author":"Pontet","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idc.2023.12.004_bib35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","article-title":"Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial","volume":"16","author":"de Jong","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idc.2023.12.004_bib36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"Schuetz","year":"2018","journal-title":"Lancet Infect Dis"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552023000909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552023000909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:32:20Z","timestamp":1760196740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552023000909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0891552023000909"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2023.12.004","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Ventilator-Associated Pneumonia","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2023.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}